These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7682019)

  • 41. Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer.
    Boorjian S; Ugras S; Mongan NP; Gudas LJ; You X; Tickoo SK; Scherr DS
    Urology; 2004 Aug; 64(2):383-8. PubMed ID: 15302512
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.
    Nakopoulou L; Constantinides C; Papandropoulos J; Theodoropoulos G; Tzonou A; Giannopoulos A; Zervas A; Dimopoulos C
    Urology; 1995 Sep; 46(3):334-40. PubMed ID: 7660508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
    Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mucin expression by transitional cell carcinomas of the bladder.
    Walsh MD; Hohn BG; Thong W; Devine PL; Gardiner RA; Samaratunga ML; McGuckin MA
    Br J Urol; 1994 Mar; 73(3):256-62. PubMed ID: 8162502
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prognostic significance of dysplastic urothelial changes for the rate of recurrence in superficial urinary bladder cancer].
    Flamm J
    Z Urol Nephrol; 1987 Nov; 80(11):641-6. PubMed ID: 3439374
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Evaluation of HER2 protein overexpression in non-muscle-invasive bladder cancer with emphasis on tumour grade and recurrence].
    Janane A; Hajji F; Ismail TO; Elondo JC; Ghadouane M; Ameur A; Abbar M; Bouzidi A
    Actas Urol Esp; 2011 Apr; 35(4):189-94. PubMed ID: 21419519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sarcomatoid carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical analysis of 14 patients.
    Ikegami H; Iwasaki H; Ohjimi Y; Takeuchi T; Ariyoshi A; Kikuchi M
    Hum Pathol; 2000 Mar; 31(3):332-40. PubMed ID: 10746676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The prognostic value of basement membrane morphology, tumour histology and morphometry in superficial bladder cancer.
    Lipponen PK
    J Cancer Res Clin Oncol; 1993; 119(5):295-300. PubMed ID: 7680044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epithelial differentiation antigens and epidermal growth factor receptors in transitional cell bladder carcinoma: correlation with prognosis.
    Nakopoulou L; Zervas A; Constantinides C; Deliveliotis C; Stefanaki K; Dimopoulos C
    Urol Int; 1995; 54(4):191-7. PubMed ID: 7541921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.
    May M; Nitzke T; Helke C; Vogler H; Hoschke B
    Scand J Urol Nephrol; 2004; 38(3):231-5. PubMed ID: 15204377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers.
    Novara G; De Marco V; Gottardo F; Dalpiaz O; Bouygues V; Galfano A; Martignoni G; Patard JJ; Artibani W; Ficarra V
    Cancer; 2007 Oct; 110(8):1715-22. PubMed ID: 17724728
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CK20 and p53 Immunohistochemical Staining Patterns in Urinary Bladder Specimens With Equivocal Atypia.
    Arias-Stella JA; Shah AB; Gupta NS; Williamson SR
    Arch Pathol Lab Med; 2018 Jan; 142(1):64-69. PubMed ID: 28967804
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of survivin in squamous cell carcinoma and transitional cell carcinoma of the urinary bladder: a comparative immunohistochemical study.
    Makboul R; Refaiy AE; Badary FA; Abdelkawi IF; Merseburger AS; Mohammed RA
    Korean J Urol; 2015 Jan; 56(1):31-40. PubMed ID: 25598934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A case report: small cell carcinoma transformed from transitional cell carcinoma of the urinary bladder].
    Hirayama T; Matsumoto K; Kurosaka S; Muramoto M; Irie A; Iwamura M; Baba S; Uchida T; Ichinohe M; Iwabuchi K
    Hinyokika Kiyo; 2006 Aug; 52(8):633-5. PubMed ID: 16972627
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The significance of bladder quadrant biopsies in patients with primary superficial bladder carcinoma.
    Flamm J; Dona S
    Eur Urol; 1989; 16(2):81-5. PubMed ID: 2714336
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
    Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
    J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urothelial tumours of the urinary bladder: a histopathological study of cystoscopic biopsies.
    Vaidya S; Lakhey M; K C S; Hirachand S
    JNMA J Nepal Med Assoc; 2013; 52(191):475-8. PubMed ID: 24907954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tissue factor expression correlates with disease-specific survival in patients with node-negative muscle-invasive bladder cancer.
    Patry G; Hovington H; Larue H; Harel F; Fradet Y; Lacombe L
    Int J Cancer; 2008 Apr; 122(7):1592-7. PubMed ID: 18058798
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder.
    Shariat SF; Kim JH; Ayala GE; Kho K; Wheeler TM; Lerner SP
    J Urol; 2003 Mar; 169(3):938-42. PubMed ID: 12576817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.